JPRN-UMIN000022856
Completed
Phase 2
Phase II study of stereotactic radiotherapy with volumetric modulated arc therapy for primary lung cancer located adjacent to organ at risk - Stereotactic radiotherapy for primary lung cancer located adjacent to organ at risk
Department of Radiuation Oncology, Tohoku University Graduate School of Medicine0 sites15 target enrollmentJuly 27, 2016
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Radiuation Oncology, Tohoku University Graduate School of Medicine
- Enrollment
- 15
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. no serious diabetes, collagen disease, cardiac disease, pulmonary disease, kidney disease and psychological disorder 2\. past history or future plan of administration of molecular target drug affecting VEGF or FGF pathways 3\. apparent interstitial pneumonitis or pulmonary fibrosis on CT images 4\.receiving home oxygen therapy 5\. Single lung 6\.pregnant or lactating woman, likelihood of pregnancy 7\. active infectious disease 8\.implanted pacemaker or implantable cardioverter defibrillator 9\. no history of thoracic radiation therapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Phase I/II study of stereotactic radiotherapy for renal cell cancerJPRN-UMIN000004172niversity of Yamanashi30
Completed
Phase 2
Phase II study of stereotactic radiosurgery with volumetric modulated arc therapy for small lung cancerJPRN-UMIN000022855Department of Radiuation Oncology, Tohoku University Graduate School of Medicine21
Completed
Phase 2
Phase II trial of stereotactic body radiotherapy with a hydrogel spacer for prostate cancerProstate cancerJPRN-UMIN000026213The University of Tokyo Hospital42
Completed
Not Applicable
Phase II trial of stereotactic body radiotherapy for non-spine bone metastases.non-spine bone metastasesJPRN-UMIN000033132Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital35
Recruiting
Phase 2
Phase II study of stereotactic radiotherapy for kidney cancer using an MR-Linac systemKidney cancer(primary kidney cancer)JPRN-UMIN000045721Tohoku University25